Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. (Q46890938)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Motoyasu Yamashita

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Setsu Fukushima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

George R Uhl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yohtaro Numachi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ichiro Sora

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

11 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

2132-2139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16407898%20AND%20SRC:MED&resulttype=core&format=json

Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition.

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Atomoxetine treatment of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Syntheses and Binding Studies of New [(Aryl)(aryloxy)methyl]piperidine Derivatives and Related Compounds as Potential Antidepressant Drugs with High Affinity for Serotonin (5-HT) and Norepinephrine (NE) Transporters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301009

7 January 2021